Clinical Trial Update: Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating escalated single platelet inhibition for one month plus a NOAC in patients with atrial fibrillation and acute coronary syndrome undergo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Acute Coronary Syndrome, Atrial Fibrillation | Phase 4 | Status: UNKNOWN